dermatan sulfate has been researched along with fibrin in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (30.00) | 18.7374 |
1990's | 5 (25.00) | 18.2507 |
2000's | 5 (25.00) | 29.6817 |
2010's | 4 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anvari, N; Blajchman, MA; Buchanan, MR; Kulczycky, M; Ofosu, FA; Okwusidi, JI | 1 |
Bourgondiën, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM | 1 |
Carr, ME; Powers, PL | 1 |
Buchanan, MR; Gray, E; Hirsh, J; Ofosu, FA; Van Ryn-McKenna, J | 1 |
Büller, HR; Henny, CP; Mooy, MC; Surachno, S; ten Cate, H; ten Cate, JW; Wilmink, JM | 1 |
Boneu, B; Dol, F; Dupouy, D; Sié, P | 1 |
Gabriel, DA; Jones, M | 1 |
Brister, SJ; Buchanan, MR | 1 |
Bendayan, P; Boccalon, H; Boneu, B; Dupouy, D | 1 |
Cadroy, Y; Hanson, SR; Harker, LA | 1 |
Fredenburgh, JC; Hirsh, J; Johnston, M; Stafford, AR; Weitz, JI; Young, E | 1 |
Becker, DL; Fredenburgh, JC; Liaw, PC; Stafford, AR; Weitz, JI | 1 |
An, J; Clark, RA; Couchman, JR; Greiling, D; Lin, F | 1 |
Cussons, P; Dye, JF; Linge, C; Potter, MJ; Sanders, R | 1 |
Asakura, H; Kabata, C; Kabata, T; Kitajima, I; Misaki, T; Tani, M; Tomita, K; Tsubokawa, T | 1 |
Kamikado, K; Kitamura, H; Liu, N; Mori, N; Muso, E; Nogaki, F; Ono, T; Otsuka, H; Sakamoto, K; Shimosawa, M; Tomari, Y; Uemura, K; Yoshida, H | 1 |
Bark, N; Blombäck, M; He, S; Johnsson, H; Wallén, NH | 1 |
Castañon, MM; Kordich, LC; Lauricella, AM; Quintana, IL | 1 |
Alves, CS; Konstantopoulos, K | 1 |
Bóta, A; Kolev, K; Komorowicz, E; Longstaff, C; Machovich, R; Rottenberger, Z; Szabó, L; Varga, Z | 1 |
2 trial(s) available for dermatan sulfate and fibrin
Article | Year |
---|---|
Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.
Topics: beta-Thromboglobulin; Blood Coagulation; Blood Platelets; Chondroitin Sulfates; Dermatan Sulfate; Factor X; Factor Xa; Female; Fibrin; Glycosaminoglycans; Heparitin Sulfate; Humans; Male; Partial Thromboplastin Time; Platelet Aggregation; Platelet Factor 4; Renal Dialysis; Thrombin Time | 1985 |
Vasoflux, a new anticoagulant with a novel mechanism of action.
Topics: Anticoagulants; Antithrombins; Blood Coagulation Tests; Dermatan Sulfate; Fibrin; Heparin; Heparin Cofactor II; Hirudins; Humans; Molecular Weight; Oxidation-Reduction | 1999 |
18 other study(ies) available for dermatan sulfate and fibrin
Article | Year |
---|---|
Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Topics: Antithrombin III; Dermatan Sulfate; Fibrin; Heparin; Heparin Cofactor II; Humans; In Vitro Techniques; Kinetics; Thrombin | 1991 |
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K | 1989 |
Effect of glycosaminoglycans on thrombin- and atroxin-induced fibrin assembly and structure.
Topics: Batroxobin; Biopolymers; Blood Coagulation; Chondroitin Sulfates; Dermatan Sulfate; Fibrin; Glycosaminoglycans; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Kinetics; Nephelometry and Turbidimetry; Thrombin | 1989 |
Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo.
Topics: Animals; Chondroitin; Dermatan Sulfate; Factor Xa; Female; Fibrin; Heparin; Kinetics; Male; Prothrombin; Rabbits; Serine Proteinase Inhibitors; Thrombin; Thrombophlebitis | 1989 |
A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.
Topics: Antithrombin III; Antithrombins; Blood Chemical Analysis; Chondroitin; Dermatan Sulfate; Fibrin; Glycoproteins; Heparin Cofactor II; Humans; Ions; Reproducibility of Results | 1988 |
Influence of the subendothelial basement membrane components on fibrin assembly. Evidence for a fibrin binding site on type IV collagen.
Topics: Basement Membrane; Cell Line; Collagen; Dermatan Sulfate; Fibrin; Fibrinogen; Kinetics; Laminin; Macromolecular Substances; Nephelometry and Turbidimetry; Protein Binding | 1988 |
Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfate.
Topics: Animals; Anticoagulants; Antithrombin III; Blood Loss, Surgical; Cardiopulmonary Bypass; Dermatan Sulfate; Fibrin; Heart Diseases; Heparin; Heparin Cofactor II; Intracranial Embolism and Thrombosis; Sternum; Surface Properties; Swine; Thoracotomy; Thrombin; Thrombosis; Whole Blood Coagulation Time | 1995 |
Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.
Topics: Dermatan Sulfate; Fibrin; Heparin; Heparin, Low-Molecular-Weight; Humans; Protein Binding; Thrombin | 1994 |
Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates.
Topics: Animals; Blood Platelets; Dermatan Sulfate; Dose-Response Relationship, Drug; Fibrin; Hemostasis; Male; Papio; Thrombin; Thrombosis | 1993 |
Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin.
Topics: Binding Sites; Dermatan Sulfate; Fibrin; Heparin; Heparin Cofactor II; Humans; Kinetics; Protein Binding; Spectrophotometry; Thrombin | 2001 |
Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan.
Topics: Adult; Cell Movement; Cells, Cultured; Chondroitin Sulfate Proteoglycans; Dermatan Sulfate; Dermis; Extracellular Matrix; Fibrin; Fibroblasts; Fibronectins; Gels; Humans; Hyaluronan Receptors; Platelet-Derived Growth Factor; Wound Healing | 2004 |
An investigation to optimize angiogenesis within potential dermal replacements.
Topics: Angiogenesis Inducing Agents; Cell Culture Techniques; Cell Movement; Chondroitin Sulfates; Collagen; Culture Media; Dermatan Sulfate; Endothelial Cells; Endothelium, Vascular; Extracellular Matrix; Female; Fibrin; Fibronectins; Gels; Glycosaminoglycans; Humans; Microspheres; Neovascularization, Physiologic; Placenta; Pregnancy; Skin, Artificial; Vascular Endothelial Growth Factor A; Vitronectin | 2006 |
Changes of the soluble fibrin monomer complex level during the perioperative period of hip replacement surgery.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Chondroitin Sulfates; Dermatan Sulfate; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Heparin; Heparitin Sulfate; Humans; Intraoperative Period; Lupus Coagulation Inhibitor; Male; Middle Aged; Postoperative Period; Venous Thromboembolism | 2008 |
Lipopolysaccharide-triggered acute aggravation of mesangioproliferative glomerulonephritis through activation of coagulation in a high IgA strain of ddY mice.
Topics: Animals; Anticoagulants; Blood Coagulation; Blotting, Western; Chemokine CCL2; Chondroitin Sulfates; Dermatan Sulfate; Factor V; Factor X; Female; Fibrin; Gene Expression; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Heparitin Sulfate; Immunoglobulin A; Immunohistochemistry; Injections, Intraperitoneal; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Proliferating Cell Nuclear Antigen; Receptor, PAR-2; Reverse Transcriptase Polymerase Chain Reaction; Thromboplastin; Toll-Like Receptor 4 | 2009 |
The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis.
Topics: Antithrombins; Arginine; Chondroitin Sulfates; Chromatography, Gel; Dermatan Sulfate; Factor VIII; Factor Xa Inhibitors; Fibrin; Fibrinolysis; Heparinoids; Heparitin Sulfate; Hirudins; Humans; In Vitro Techniques; Microscopy, Confocal; Peptide Fragments; Pipecolic Acids; Plasma; Porosity; Protein Multimerization; Recombinant Proteins; Sulfonamides; Thrombosis; Tissue Plasminogen Activator | 2010 |
Alterations of fibrin network structure mediated by dermatan sulfate.
Topics: Animals; Anticoagulants; Cattle; Dermatan Sulfate; Fibrin; Protein Binding | 2013 |
PDGF suppresses the sulfation of CD44v and potentiates CD44v-mediated binding of colon carcinoma cells to fibrin under flow.
Topics: Binding, Competitive; Cell Adhesion; Cell Culture Techniques; Cell Line, Tumor; Chondroitin; Colonic Neoplasms; Dermatan Sulfate; Fibrin; Fibrinogen; Flow Cytometry; HL-60 Cells; Humans; Hyaluronan Receptors; Hyaluronic Acid; Immobilized Proteins; Immunoprecipitation; Microspheres; Platelet-Derived Growth Factor; Protein Binding; Selectins; Stress, Mechanical; Sulfates | 2012 |
Lytic and mechanical stability of clots composed of fibrin and blood vessel wall components.
Topics: Animals; Blood Coagulation; Blood Vessels; Cattle; Chondroitin Sulfates; Collagen; Decorin; Dermatan Sulfate; Extracellular Matrix Proteins; Fibrin; Fibrinolysis; Glycosylation; Humans; Kinetics; Matrix Metalloproteinase 8; Microscopy, Electron, Scanning; Peptide Fragments; Plasminogen; Rheology; Stress, Mechanical; Tissue Plasminogen Activator | 2013 |